LifeSpan Cancer Institute is a clinical research site located in Providence, Rhode Island, United States 09206.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
LifeSpan Cancer Institute has participated in 1 clinical trials.
Therapeutic areas: Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Neoplasm.
Sponsors: Progenics Pharmaceuticals, Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
LifeSpan Cancer Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
LifeSpan Cancer Institute has 1 clinical trials on record. Their work covers Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Neoplasm.
LifeSpan Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.